Sorafenib tosylate 98.0%~102.0% Frontida
Sorafenib is a new multi kinase inhibitor antitumor drug, which can act on tumor cells and tumor blood vessels at the same time.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View